Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu
Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals
BioPharma Dive
Fri, 12/20/19 - 08:19 pm
Daiichi Sankyo
AstraZeneca
FDA
drug approvals
breast cancer
trastuzumab deruxtecan
Drugmakers rebranding around oncology, rare diseases could provide 2020 preview
Fierce Pharma
Thu, 12/19/19 - 11:32 pm
oncology
Rare Diseases
AstraZeneca
GSK
Alexion
Takeda
Soliris
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
Thu, 12/19/19 - 01:05 pm
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
AZ, Merck's Lynparza narrowly snags FDA panel backing in pancreatic cancer
Fierce Pharma
Tue, 12/17/19 - 09:19 pm
AstraZeneca
Merck
Lynparza
pancreatic cancer
FDA
advisory panels
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Tue, 12/17/19 - 10:34 am
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
Pharmaceutical Business Review
Tue, 12/17/19 - 10:25 am
AstraZeneca
Seroquel
Seroquel XR
Russia
Europe
Cheplapharm
Is AZ, Merck's Lynparza approvable in pancreatic cancer sans survival benefit? FDA's about to decide
Fierce Pharma
Mon, 12/16/19 - 10:42 am
AstraZeneca
Merck
Lynparza
FDA
BRCA-mutated pancreatic cancer
pancreatic cancer
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
AZ’s Imfinzi approved in early lung cancer in China
Pharmaforum
Thu, 12/12/19 - 10:55 am
China
AstraZeneca
Imfinizi
non-small cell lung cancer
SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance
EP Vantage
Wed, 12/11/19 - 10:24 am
breast cancer
AstraZeneca
Daiichi Sankyo
SABCS
trastuzumab deruxtecan
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets
Xconomy
Mon, 12/9/19 - 09:40 am
AstraZeneca
Gatehouse Bio
R&D
Respiratory
Cardiovascular
sRNA
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
AstraZeneca Sells off Seroquel Rights in U.S. and Canada
BioSpace
Tue, 12/3/19 - 10:44 pm
AstraZeneca
Cheplapharm
Seroquel
Seroquel XR
bipolar disorder
schizophrenia
'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
Fierce Biotech
Tue, 12/3/19 - 10:20 pm
Biogen
AstraZeneca
lupus
Amgen clinical trials
BIIB059
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
AstraZeneca
diabetes
type 2 diabetes
heart failure
AstraZeneca, Novoheart to Co-Develop New Heart Model
Xconomy
Wed, 11/27/19 - 10:40 am
AstraZeneca
Novoheart
heart-in-a-jar
heart failure
[release] eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists
CP Wire
Mon, 11/25/19 - 01:02 pm
cloud platforms
commercialization
training
sales reps
ACTO
AstraZeneca
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
Mon, 11/25/19 - 09:46 am
AstraZeneca
FDA
CLL
SLL
Calquence
AstraZeneca CEO: Closing In On A Cancer Cure
Yahoo/Benzinga
Sat, 11/23/19 - 04:20 pm
AstraZeneca
Pascal Soriot
oncology
cancer
Pages
« first
‹ previous
…
46
47
48
49
50
51
52
53
54
…
next ›
last »